Company Filing History:
1 out of 223 
1 out of 41 
Years Active: 2016
Title: Ludo Van Den Bosch: Innovator in Neurological Research
Introduction
Ludo Van Den Bosch is a prominent inventor based in Arendonk, Belgium. He has made significant contributions to the field of neurological research, particularly in the treatment of hereditary neuropathies such as Charcot-Marie-Tooth (CMT) disease. His innovative work has led to the development of a patent that addresses critical issues in peripheral nervous system diseases.
Latest Patents
Ludo Van Den Bosch holds a patent for HDAC inhibitors to treat Charcot-Marie-Tooth disease. The patent disclosure highlights that CMT disease is associated with decreased acetylated tubulin levels, which can be mitigated by inhibiting histone deacetylases (HDACs). His research demonstrates that using HDAC inhibitors can alleviate the symptoms of the CMT phenotype both in vitro and in vivo. Additionally, he has provided two different mouse models of CMT disease to further support his findings.
Career Highlights
Throughout his career, Ludo Van Den Bosch has worked with notable organizations such as Vib Vzw and Life Sciences Research Partners Vzw. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in neurology.
Collaborations
Ludo has collaborated with esteemed colleagues, including Constantin Van Outryve d'Ydewalle and Wim Robberecht. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Ludo Van Den Bosch is a dedicated inventor whose work in HDAC inhibitors has the potential to transform the treatment of Charcot-Marie-Tooth disease. His innovative approach and collaborations highlight the importance of research in addressing complex neurological disorders.